Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect

被引：0
|
作者：
F. Puisset
E. Chatelut
A. Sparreboom
J.-P. Delord
D. Berchery
I. Lochon
T. Lafont
H. Roché
机构：
[1] EA3035,
[2] Institut Claudius-Regaud,undefined
[3] St. Jude Children’s Research Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Cytochrome P450 3A4/5; Dexamethasone; Docetaxel; Pharmacokinetics; Gender;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：305 / 308
页数：3
相关论文
共 50 条
  • [31] The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites
    Chapron, Brian D.
    Dinh, Jean C.
    Toren, Paul C.
    Gaedigk, Andrea
    Leeder, J. Steven
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (11) : 1113 - 1120
  • [32] Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
    Kummer, Oliver
    Hammann, Felix
    Moser, Claudine
    Schaller, Olivier
    Drewe, Juergen
    Kraehenbuehl, Stephan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (01) : 63 - 71
  • [33] Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates
    Saiz-Rodriguez, Miriam
    Almenara, Susana
    Navares-Gomez, Marcos
    Ochoa, Dolores
    Roman, Manuel
    Zubiaur, Pablo
    Koller, Dora
    Santos, Maria
    Mejia, Gina
    Borobia, Alberto M.
    Rodriguez-Antona, Cristina
    Abad-Santos, Francisco
    BIOMEDICINES, 2020, 8 (04)
  • [34] The impact of CYP3A4 genetic polymorphism on crizotinib metabolism and drug-drug interactions
    Wang, Jing
    Xu, Xiao-yu
    Li, Xin-yue
    Luo, Jian-chao
    Zhang, Zhe-yan
    Chen, Jing
    Cai, Jian-ping
    Zhang, Li-kang
    Qian, Jian-chang
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2024, 489
  • [35] Functional evaluation of vandetanib metabolism by CYP3A4 variants and potential drug interactions in vitro
    Han, Mingming
    Zhang, Xiaodan
    Ye, Zhize
    Wang, Jing
    Qian, Jianchang
    Hu, Guoxin
    Cai, Jianping
    CHEMICO-BIOLOGICAL INTERACTIONS, 2021, 350
  • [36] The independent contribution of miRNAs to the missing heritability in CYP3A4/5 functionality and the metabolism of atorvastatin
    Liu, Ju-E
    Ren, Bin
    Tang, Lan
    Tang, Qian-Jie
    Liu, Xiao-Ying
    Li, Xin
    Bai, Xue
    Zhong, Wan-Ping
    Meng, Jin-Xiu
    Lin, Hao-Ming
    Wu, Hong
    Chen, Ji-Yan
    Zhong, Shi-Long
    SCIENTIFIC REPORTS, 2016, 6
  • [37] Amlodipine Metabolism in Human Liver Microsomes and Roles of CYP3A4/5 in the Dihydropyridine Dehydrogenation
    Zhu, Yanlin
    Wang, Fen
    Li, Quan
    Zhu, Mingshe
    Du, Alicia
    Tang, Wei
    Chen, Weiqing
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (02) : 245 - 249
  • [38] THE HEPATIC CYP3A4 UPREGULATED INCREASED METABOLISM IN RESPONSE TO PHYSICAL ACTIVITY AT HIGH ALTITUDE
    Thomas, Abhilash
    Samanta, Malay K.
    Chauhan, Raveen
    Jose, Sanesh P.
    Moktan, Jeet B.
    Sridharamurthy, N. B.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (07): : 3359 - 3363
  • [39] Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
    Oliver Kummer
    Felix Hammann
    Claudine Moser
    Olivier Schaller
    Jürgen Drewe
    Stephan Krähenbühl
    European Journal of Clinical Pharmacology, 2011, 67 : 63 - 71
  • [40] Effect of CYP3A4 and CYP3A5 Genetic Polymorphisms on the Pharmacokinetics of Sirolimus in Healthy Chinese Volunteers
    Zhang, Jing
    Dai, Ying
    Liu, Zhihong
    Zhang, Minxin
    Li, Chen
    Chen, Dingxiong
    Song, Hongtao
    THERAPEUTIC DRUG MONITORING, 2017, 39 (04) : 406 - 411
12345